ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

Heath D Skinner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.